EP2655370
Samsetningar og aðferðir til að móta FRX
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
30.11.2011EP published:
2.8.2017EP application number:
11796872.7
EP translation filed:
28.8.2017Grant published:
15.9.2017EPO information:
European Patent Register
Max expiry date:
29.11.2031Expiry date:
29.11.2022
Title:
COMPOSITIONS AND METHODS FOR MODULATING FXR
Timeline
Today
30.11.2011EP application
2.8.2017EP Publication
28.8.2017Translation submitted
15.9.2017Registration published
29.11.2022Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
TULLY, David C.Address:
San Diego, CA, US
Name:
RUCKER, Paul VincentAddress:
San Diego, CA, US
Name:
ALPER, Phillip B.Address:
San Diego, CA, US
Name:
MUTNICK, DanielAddress:
San Diego, CA, US
Name:
CHIANELLI, DonatellaAddress:
San Diego, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201061425189 PDate:
20.12.2010Country:
US
Number:
201161554297 PDate:
1.11.2011Country:
US
Classification
Categories:
C07D 451/06, A61K 31/46, A61P 3/00, C07D 471/04, C07D 487/04
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 13.9.2017
Expires: 29.11.2018
Payer: Árnason Faktor
Number: 8
Paid: 23.10.2018
Expires: 29.11.2019
Payer: Árnason Faktor
Number: 9
Paid: 24.10.2019
Expires: 29.11.2020
Payer: Árnason Faktor
Number: 10
Paid: 27.10.2020
Expires: 29.11.2021
Payer: Árnason Faktor ehf.
Number: 11
Paid: 27.10.2021
Expires: 29.11.2022
Payer: Árnason Faktor ehf.